Navigation Links
Lumenis Ltd. Announces Appointment of Corporate Vice President, Business Development in support of the company's long-term growth strategy
Date:10/18/2007

Gideon Sturlesi has been named new Corporate Vice President, Business Development to spearhead global business activities. Lumenis reaffirms its commitment to growing its business and moving forward strongly on many

strategic fronts

YOKNEAM, Israel, Oct. 18 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications, announced the appointment of Gideon Sturlesi, a highly experienced executive in the medical devices industry, as Corporate Vice President, Business Development, effective November 18th 2007.

In addition to leading the corporate business development initiatives, Gideon will be responsible for managing the Lumenis veterinarian and dental activities, as well as the company's intellectual property strategy and portfolio.

Gideon Sturlesi was the founder and general partner of BioMedical Israel Ltd., a life-science private fund group, heading successful M&A processes, turn-arounds and "hands-on" management in it's portfolio companies. In addition, Gideon is a Venture Partner in the Ofer Hi-Tech Group, a leading investment company in life science technology-based businesses from pre-seed through early stages to public offerings. He was also the co-founder of Galil Medical Ltd., a developer of minimal invasive devices for use in urology, general surgery and other applications. Gideon Sturlesi holds a BSc and MSc (cum-laude) from the Technion Institute of Technology, Israel, and holds over 7 patents and publications in medical device technology.

Dov Ofer, CEO of Lumenis said: "We are proud to have Gideon Sturlesi as part of our executive management team. Gideon's background and proven capabilities will have a significant contribution in implementing our aggressive growth strategies. Gideon's appointment also supports the emphasis the company places on our intellectual property portfolio, one of Lumenis' major assets. With Gideon's appointment we have completed the line-up of our executive management team which is fully focused on executing our growth and profitability plans. I look forward to working hand in hand with our outstanding management team and Board of Directors to achieve Lumenis' fullest potential for the benefit of our customers, shareholders, employees and business partners."

About Lumenis Ltd.

Lumenis Ltd. is a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis Ltd. invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis Ltd. and its products, log onto: http://www.lumenis.com

Lumenis(R) is a registered trademark of Lumenis Ltd.


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... Denmark , March 22, 2017  Ascendis ... utilizes its innovative TransCon technology to address significant ... financial results for the full year ended December ... significant year for our company as we broadened ... a leading, integrated rare disease company with an ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
Breaking Biology Technology:
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 8, 2017 About Voice Recognition Biometrics ... match it against a stored voiceprint template. Acoustic ... cadence, and tone are compared to distinguish between ... installation, as most PCs already have a microphone ... Voice recognition biometrics are most likely to be ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
Breaking Biology News(10 mins):